Point72 Middle East FZE’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,148
Closed -$40.1K 100
2023
Q4
$40.1K Buy
13,148
+10,941
+496% +$33.4K ﹤0.01% 766
2023
Q3
$6.62K Sell
2,207
-6,375
-74% -$19.1K ﹤0.01% 837
2023
Q2
$32.1K Buy
+8,582
New +$32.1K ﹤0.01% 806
2023
Q1
Sell
-2,287
Closed -$11K 1088
2022
Q4
$11K Buy
+2,287
New +$11K ﹤0.01% 1170